Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Sponsor: National Cancer Institute, Naples
Summary
The study involves the use of reagents or materials for diagnostic assessments that are not commercially available, specifically a metabolomic signature for screening endometrial carcinoma and/or other types of cancers, and follows a case-control design. This study aims to achieve several objectives that contribute to evaluating the diagnostic potential of a specific "metabolomic signature" to be used for screening endometrial carcinoma. Specifically, the study seeks to assess the signature's discriminative ability in differentiating between benign endometrial neoplasms and neoplasms of different histological origins.
Key Details
Gender
FEMALE
Age Range
50 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
3100
Start Date
2023-07-06
Completion Date
2025-07
Last Updated
2025-03-25
Healthy Volunteers
Yes
Conditions
Interventions
Metabolomic profiling
Blood samples will be collected from these subjects, and following metabolomic profiling, the data will provide the foundation for training machine learning models capable of recognizing the metabolomic profiles of subjects with endometrial carcinoma and differentiating them from subjects with other conditions.
Locations (1)
Istituto Nazionale Tumori | "Fondazione Pascale"
Naples, Italy